Fulcrum Therapeutics ( FULC) on Saturday reported positive initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease.

FLMI offers diversified muni bond exposure with modest yield, mid-tenor positioning and limited appeal versus higher-yield ...

Yellow Cake provides passive uranium exposure with stored inventory, strong performance and supportive sector trends. Find ...

Vertical Aerospace (EVTL) has announced a new long-term supplier partnership critical to the production of Vertical’s ...

Discover why Rubrik (RBRK) is a strong buy with robust AI-driven growth, solid earnings, and 33% upside potential.

Beauty sees a sharp drop, Q2 miss, price shifts, solid demand, global growth and long-term potential supporting outlook. See ...

Under the definitive agreements, Biocon will acquire all of Viatris' ( VTRS) convertible preferred equity in Biocon Biologics ...

Discover why Himax Technologies (HIMX) is downgraded as automotive IC sales drop. Learn the outlook, risks, and future growth ...

Panasonic Holdings Corporation ( PCRHY) Analyst/Investor Day December 1, 2025 7:00 PM EST ...

2026 will likely be the year when we will start to see serious flaws, with the pure fiat global monetary system exposed. The ...

We have all heard about the “K-shaped” economy, and looking at how dollar stores’ stocks fared so far this year certainly ...

PBF’s trailing valuation is currently influenced by several quarters of negative EBITDA generation. However, if Q3’s ...